What is the purpose of this trial?
The purpose of this study is to determine whether add-on TAK-831 is superior to placebo on the Positive and Negative Syndrome Scale Negative Symptom Factor Score (PANSS NSFS).
Ages: 18 - 50 years
Takeda Pharmaceuticals, America, Inc.
Start Date: 03/28/2018
End Date: 04/20/2020
Last Updated: 01/17/2019
Study HIC#: 2000022363